Results 301 to 310 of about 175,835 (341)
Some of the next articles are maybe not open access.
The Laryngoscope, 1974
AbstractSarcoidosis is a protean disease which may involve several anatomic sites often examined by the otolaryngologist. Sarcoidosis of the nasal mucosa may cause nasal obstruction, especially in the presence of a concomitant deviated nasal septum. The authors review current knowledge pertaining to the etiology, pathology, diagnosis, and treatment as ...
R E, Wright +3 more
openaire +2 more sources
AbstractSarcoidosis is a protean disease which may involve several anatomic sites often examined by the otolaryngologist. Sarcoidosis of the nasal mucosa may cause nasal obstruction, especially in the presence of a concomitant deviated nasal septum. The authors review current knowledge pertaining to the etiology, pathology, diagnosis, and treatment as ...
R E, Wright +3 more
openaire +2 more sources
Intranasal Naloxone Administration
New England Journal of Medicine, 2021Intranasal Administration of Naloxone Intranasal naloxone is used to treat patients with respiratory and central nervous system depression that is known or suspected to be caused by an opioid overd...
Rafael Ortega +4 more
openaire +4 more sources
Expert Opinion on Pharmacotherapy, 2005
Intranasal zolmitriptan has recently been launched in the US and Canada and is a novel formulation of the antimigraine drug zolmitriptan. This drug has been used extensively in its oral formulation. The intranasal formulation offers a more rapid onset of action.
Marek, Gawel, Irene, Worthington
openaire +2 more sources
Intranasal zolmitriptan has recently been launched in the US and Canada and is a novel formulation of the antimigraine drug zolmitriptan. This drug has been used extensively in its oral formulation. The intranasal formulation offers a more rapid onset of action.
Marek, Gawel, Irene, Worthington
openaire +2 more sources
Drugs, 1999
Intranasal metoclopramide is a new formulation of an established and effective antiemetic drug. Absorption after intranasal administration was lower than after oral or intravenous administration; otherwise the pharmacodynamic and pharmacokinetic profiles of the intranasal and parenteral formulations were similar.
D, Ormrod, K L, Goa
openaire +2 more sources
Intranasal metoclopramide is a new formulation of an established and effective antiemetic drug. Absorption after intranasal administration was lower than after oral or intravenous administration; otherwise the pharmacodynamic and pharmacokinetic profiles of the intranasal and parenteral formulations were similar.
D, Ormrod, K L, Goa
openaire +2 more sources
American Journal of Otolaryngology, 2000
Glomangiomas of the nasal cavity are a rare occurrence. Only 9 cases of this vascular tumor have been reported in the literature. A case of intranasal glomangioma is reported with a review of pertinent literature. The histogenesis, clinical presentation, diagnosis, immunohistochemical features, and treatment of these rare tumors are presented.
R D, Cullen, E Y, Hanna
openaire +2 more sources
Glomangiomas of the nasal cavity are a rare occurrence. Only 9 cases of this vascular tumor have been reported in the literature. A case of intranasal glomangioma is reported with a review of pertinent literature. The histogenesis, clinical presentation, diagnosis, immunohistochemical features, and treatment of these rare tumors are presented.
R D, Cullen, E Y, Hanna
openaire +2 more sources
The Turkish Journal of Ear Nose and Throat, 2013
Angiofibrolipoma is a rarely seen histopathological variant of lipoma. It is seldom in the head and neck region. Clinically, it shows macroscopic similarity with lipoma. In this article, we report a 65-year-old male case who presented with left-sided nasal obstruction.
ÇETİN, Mehmet Ali +6 more
openaire +4 more sources
Angiofibrolipoma is a rarely seen histopathological variant of lipoma. It is seldom in the head and neck region. Clinically, it shows macroscopic similarity with lipoma. In this article, we report a 65-year-old male case who presented with left-sided nasal obstruction.
ÇETİN, Mehmet Ali +6 more
openaire +4 more sources
Clinical Pharmacokinetics, 1992
Insulin administered nasally has considerable potential for the treatment of both insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) diabetes. For patients with NIDDM it is possible to prevent preprandial hyperglycaemia and postprandial hypoglycaemia by employing a suitable and properly timed intranasal insulin dose.
L, Illum, S S, Davis
openaire +2 more sources
Insulin administered nasally has considerable potential for the treatment of both insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) diabetes. For patients with NIDDM it is possible to prevent preprandial hyperglycaemia and postprandial hypoglycaemia by employing a suitable and properly timed intranasal insulin dose.
L, Illum, S S, Davis
openaire +2 more sources